1. Anti-inflammatory Metabolites from Chaetomium nigricolor
- Author
-
Seung Mok Ryu, Min Jee Kim, Haeun Kwon, Hyuncheol Oh, Dong-Cheol Kim, Youn-Chul Kim, Dongho Lee, Seung Beom Hong, Yuanqiang Guo, and Jaeyoung Kwon
- Subjects
Pharmacology ,010405 organic chemistry ,medicine.drug_class ,Chemistry ,Kinase ,Organic Chemistry ,Pharmaceutical Science ,Interleukin ,01 natural sciences ,Anti-inflammatory ,0104 chemical sciences ,Analytical Chemistry ,Nitric oxide ,010404 medicinal & biomolecular chemistry ,Enzyme activator ,chemistry.chemical_compound ,Complementary and alternative medicine ,Biochemistry ,Drug Discovery ,medicine ,Molecular Medicine ,Tumor necrosis factor alpha ,Prostaglandin E2 ,RAW 264.7 Cells ,medicine.drug - Abstract
Twelve metabolites were obtained from the culture media of Chaetomium nigricolor, including a new furan derivative, methyl succinyl Sumiki's acid (1), and two new atropisomers of the previously reported bis-naphtho-γ-pyrones, (aS)-asperpyrone A and (aS)-fonsecinone A (2 and 3). The structures were elucidated by spectroscopic, chemical, and chiroptical techniques. Compounds 2 and 3 inhibited nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 macrophages. Compound 2 was found to inhibit nuclear factor-kappa B and c-Jun N-terminal kinase activation, in turn suppressing pro-inflammatory mediators and cytokines including nitric oxide, prostaglandin E2, interleukin (IL)-1β, tumor necrosis factor-α, IL-6, and IL-12.
- Published
- 2020
- Full Text
- View/download PDF